Biopolymers and filler substances · Mexico

Biopolymer removal: medical assessment and treatment

Medical care for people with complications from injected filler substances (liquid silicone, oils, paraffin, polyacrylamide). COFEPRIS, Mexico’s health regulator, considers them a high risk to health.

  • Assessment with imaging
  • Personalized plan
  • Laser technology as support
  • Medical and surgical approach

Reviewed by clinicaobesidadenvejecimiento.com · Last review:

Reception of Clínica Obesidad y Envejecimiento in Mexico City
✓COFEPRIS health alert on filler substances (2023)
In short

Biopolymers, or filler substances, are unauthorized materials injected to add volume. They can cause inflammation, hardening, pain, skin changes and even damage to other organs, sometimes years later. Treatment starts with a medical assessment and imaging studies to locate the material. Depending on the case, it combines medical management with removal of the material in localized areas, supported by laser technology. Evidence shows that removing 100% is not always possible, so the goal is to control symptoms and safely remove as much material as possible.

What it treats
Complications from filler substances
Common areas
Buttocks, legs, breasts and face
Tests
MRI and lab work
Approach
Medical and surgical, case by case
Background

What biopolymers and iatrogenic allogenosis are

In 2023, COFEPRIS warned about non-absorbable filler substances used in cosmetic procedures: liquid or gel silicone, petroleum jelly, paraffin, polyacrylamide, vegetable or motor oils, guaiacol and beeswax, among others. The Mexico City Health Protection Agency also issued a risk notice.

Plastic surgeon Felipe Coiffman proposed the term iatrogenic allogenosis for the disease these materials cause in the body.

It can appear years later

In the experience of the Hospital General de México, symptoms appeared anywhere from weeks to 30 years after the injection. Anyone who received these substances in the past should watch for any change.

Warning signs

Symptoms that need assessment

In the injected area

  • Swelling, redness or warmth
  • Hardening, lumps or irregularities
  • Color changes or skin ulcers
  • Pain, migration of the material or fluid discharge

Elsewhere in the body

  • Joint pain
  • General inflammatory reactions
  • Kidney, liver or lung problems
  • Persistent fatigue and malaise

Symptoms described in the Hospital General de México series and in the COFEPRIS alert.

Process

How it is assessed and treated

Assessment

Medical history: which substance, when and where it was applied, and current symptoms.

Imaging

MRI shows the extent of the material and the affected tissue.

Medical management

Control of inflammation and symptoms before any surgery.

Removal and reconstruction

Removal of the material in localized areas, with laser support, and reconstruction when needed.

This is the approach described by the Hospital General de México: multidisciplinary care, with medical management as the foundation and surgery when the tissue is ready.

Treatment options

What options exist according to the evidence

OptionWhen it is consideredSource
Medical management (anti-inflammatories and other drugs as needed)Foundation of treatment to control inflammationHospital General de México, 2013
Surgical removal of the materialLocalized masses, when the tissue allows; sometimes in several sessionsCoiffman, 2008 · JPRAS Open, 2025
Laser technology as supportAs a tool during removal; published evidence on its specific use is limitedSystematic review, 2025
Reconstruction with the patient’s own tissueTo correct depressions or defects after removalHospital General de México, 2013
Scientific evidence

What the studies say

128

Patients operated on for filler-substance disease at the Hospital General de México under a multidisciplinary protocol.

Cir Plast Iberolatinoam, 2013
42.9%

Of patients had no complications after open gluteal removal in a series of 35 cases; the most frequent was seroma.

JPRAS Open, 2025
250

Patients in a Latin American series that proposes treatment by clinical stage.

Cir Plast Iberolatinoam, 2022

Complications of surgical removal

ComplicationFrequencySource
Seroma (fluid collection)40%JPRAS Open, 2025
Wound opening28.6%JPRAS Open, 2025
Wound infection14.3%JPRAS Open, 2025

In that series, infections resolved with oral antibiotics and seromas with drainage. There is also a staging system to classify the gluteal reaction and plan treatment.

Safety

How to choose where to get care

COFEPRIS recommends:

  • Only seeing accredited health professionals.
  • Checking that the doctor is listed by the Mexican Council of Plastic, Aesthetic and Reconstructive Surgery.
  • Confirming their training as a plastic surgeon and membership in medical associations.
  • Filing a health complaint if a place is found applying these substances.
Myth and fact

Points worth clarifying

“100% of the material can be removed.”

Not always. Coiffman recommends resecting only limited areas, and the goal is to remove what is safe and control symptoms.

“If it doesn’t hurt, nothing is wrong.”

Symptoms can appear decades after the injection, according to the Hospital General de México.

“They are safe if applied by someone experienced.”

COFEPRIS considers them a high health risk, regardless of who applies them.

“Laser melts and removes all the biopolymer.”

Laser is a supporting tool; published evidence on its specific use is limited and it is always combined with a full assessment.

Frequently asked questions

Questions about biopolymer removal

How do I know if I have biopolymers?

If you ever had a substance injected to add volume outside a certified medical office, an assessment is advisable. MRI can locate the material.

Can all the material be removed?

Not always. It depends on the amount, the area and how it spread. The goal is to remove what is safe and control symptoms.

What tests are needed?

Usually an MRI of the area and lab tests, depending on the case, as described by the Hospital General de México.

Which areas are affected?

Most often the buttocks, legs, breasts and face, where these substances are most commonly injected.

Does removal have risks?

Yes. In a series of 35 patients, the most frequent complication was seroma, which resolved with drainage.

What should I do if I have symptoms?

Get a medical assessment. COFEPRIS recommends seeing certified plastic surgeons.

Downloadable quick guide. The essentials about biopolymers in one image: what they are, warning signs, how they are assessed and what to expect from treatment.

Download infographic (PNG)

Have you had a filler substance injected?

Book a medical assessment to examine the area, locate the material with imaging and define the right plan.

Book an assessment on WhatsApp

Río Ródano 510, Cuauhtémoc, 06500 Mexico City · +52 55 3522 3243

Sources

  1. COFEPRIS. Filler substances used in cosmetic procedures pose a high health risk. Statement 96/2023. gob.mx
  2. Mexico City Health Protection Agency. Risk notice on the use of filler substances. AGEPSA CDMX
  3. Gordillo-Hernández J, et al. Multidisciplinary approach to human disease from infiltration of filler substances. Hospital General de México. Cir Plast Iberolatinoam. 2013;39(3). SciELO
  4. Coiffman F. Iatrogenic allogenosis: a new disease. Cir Plast Iberolatinoam. 2008;34(1). SciELO
  5. Allogenosis from biomaterials, our experience. Cir Plast Iberolatinoam. 2022. SciELO
  6. Eusse Llanos JC, Posada López S. Paramedian open approach for gluteal biopolymers removal: a case series of 35 patients. JPRAS Open. 2025;45:425-435. PubMed Central
  7. A staging system for gluteal foreign body reaction to injectables. J Plast Reconstr Aesthet Surg. ScienceDirect
  8. Foreign body granulomas reaction related to collagen stimulatory cosmetic fillers: a systematic review. 2025. PubMed Central